Tagged with ROche

Ecuador The top 20 pharma companies in Ecuador in 2017, ranked by value, for both the retail and public markets. Argentinian firm Roemmers leads the way in the retail market, followed by global players Bayer and Sanofi. In terms of Ecuador’s public market, the top three companies are global giants Roche,…

Estonia Kadri Maegi-Lehtsi, general manager of Roche Pharmaceuticals Estonia, discusses the company’s established footprint in the Estonian market and their mission to give back to the Estonian society not only by providing innovative and highly needed medicines, but also through awareness and lifestyle campaigns. In Estonia, Roche focuses on marketing and…

Baltics Rauls Velins, Roche’s general manager for Latvia, introduces the company’s longstanding commitment to the Latvian market, Roche’s role in helping facilitate Latvia’s new National Cancer Plan, and the potential for personalized medicine across the Baltics. Could you please start by introducing Roche in Latvia and the strategic significance of the…

Ecuador Antonio Carlos Matos da Silva, general manager of Roche Ecuador explains how his ability to manage by influence has helped him transition smoothly into his first GM position. The Brazilian manager has great ambitions for the Ecuadorian affiliate of the oncology global giant, elaborating on Vision 2020; a plan he…

Brazil When combining the sheer size of Brazil – the fifth largest country in the world – with its tropical climate, its largely perfectible infrastructure, and the soaring importance of temperature sensitive biologicals, one understands the urgent need to develop solutions guaranteeing appropriate transport conditions in Brazil. “We may be vaguely…

Canada Whitney Green candidly describes what first surprised him as an American coming to Canada to head up operations as president and general manager of Roche Diagnostics Canada. He highlights the benefits the innovative portfolio of Roche Diagnostics can bring to Canada, its potential in driving forward personalized healthcare and the…

Pharma The top 10 pharmaceutical companies in Canada for 2016 in terms of total sales and market share. Johnson & Johnson leads the way with USD 2.93 billion in sales, followed by Novartis with USD 1.24 billion and TEVA with USD 1.19 billion.

India For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India still stands as a land of opportunity for a variety of reasons. Novartis India country president Jawed Zia points out that “India, in terms of demographics, is the youngest nation in the world. The…

Brazil Rolf Hoenger, president and general manager of Roche Pharma Brazil, provides an inspiring insight into the innovative and multi-faceted market access vision implemented by the Brazilian affiliate under his tenure and documents his personal approach to bolstering creativity at the affiliate level and ultimately fulfill the company’s fundamental objective to…

India A strong advocate for women’s health and the first managing director of Roche Diagnostics India to be under 40 years old, Dr. Shravan Subramanyam shares his insights on the Indian healthcare system, the value proposition of diagnostics to patients, the importance of public-private partnership in making quality healthcare more accessible…

India India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the leading country in its region. Despite the prevalence of gender disparity in India, where only two percent of women attain leadership positions; several inspirational women are blazing trails…

Canada Ronnie Miller, President & CEO of Roche Canada, shares the lessons learnt over his 17 years heading the affiliate, the interesting dynamics and developments within the Canadian healthcare space, Roche’s significant R&D footprint in Canada, and his focus on developing Roche Canada’s multiple sclerosis, hemophilia and neuroscience portfolios over the…